Reaction
Genital Ulceration reporting signals
As of the last recalculation, Genital Ulceration appears in 747 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is TRIMETHOPRIM (PRR 102.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Trimethoprim | 41 | 102.5 | 102.8 |
| Tamsulosin Hydrochloride | 19 | 26.6 | 26.6 |
| Adalimumab-Fkjp | 41 | 26.0 | 26.1 |
| Zinc | 22 | 25.6 | 25.6 |
| Zinc Chloride | 22 | 25.4 | 25.4 |
| Adalimumab-Aaty | 40 | 24.8 | 24.8 |
| Zinc Gluconate | 22 | 24.1 | 24.1 |
| Adalimumab-Adaz | 40 | 22.3 | 22.3 |
| Fexofenadine | 12 | 20.6 | 20.6 |
| Nevirapine | 5 | 15.5 | 15.5 |
| Fesoterodine Fumarate | 5 | 12.9 | 12.9 |
| Cabozantinib | 20 | 11.9 | 11.9 |